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Abstract In this review, we critically assess recent evidence
from human studies regarding the potential implications of
exposure to maternal diabetes in-utero for long-term adiposity,
cardiometabolic outcomes, and cognitive ability of the off-
spring. Evidence supports a direct causal role for exposure to
maternal diabetes in utero in determining offspring long-term
greater adiposity and adverse cardiometabolic health. Al-
though a majority of observational studies report associations
of exposure to maternal pregnancy diabetes with lower cog-
nitive ability, there is also evidence supporting an opposite
‘protective’ intrauterine effect of exposure to maternal preg-
nancy diabetes on offspring cognitive ability. Epigenetic mod-
ification has been suggested as a mediator on the pathways
from maternal pregnancy diabetes to long-term offspring out-
comes and several recent studies that are reviewed here lend
some support to this notion, but research in this area is still too
novel to be conclusive.
Keywords Pregnancy diabetes . Developmental
overnutrition . Cognitive ability . Adiposity . Cardiometabolic
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Introduction
Diabetes in pregnancy can be 1 of the following 3 types of
diabetes: pre-existing type 1 diabetes (present before
pregnancy), pre-existing type 2 diabetes, or gestational diabe-
tes, (ie, diabetes with onset or first diagnosis in pregnancy).
Increases in the prevalence of all 3 types of pregnancy diabe-
tes have been noted in recent years [1–4], with virtually
identical US and UK estimates suggesting that gestational
diabetes accounts for the majority of diabetic pregnancies
(~87 %) and, type 1 diabetes for an additional 7 % and type
2 diabetes for 5% [5, 6]. Although the USNational Institute of
Health recently estimated the prevalence of gestational diabe-
tes to be 5 %–6 % [7], other studies have yielded estimates as
high as 14 % [8, 9].
Perinatal complications of a diabetic pregnancy include
macrosomia, hypoglycemia, respiratory distress syndrome,
polycythemia, hyperbilirubinemia, cardiomyopathy, congeni-
tal abnormalities, and sudden infant death. These have been
extensively reviewed elsewhere in recent years [10], including
in this Journal [11], and are not the focus here. The purpose of
the current review is to summarize and discuss recent evidence
from human studies regarding the potential implications of
exposure to maternal pregnancy diabetes in utero for offspring
long-term greater adiposity and adverse cardiometabolic out-
comes, and cognitive ability, with the outcomes examined
reflecting the latest and most extensive work on long-term
offspring health outcomes following in-utero exposure to ma-
ternal diabetes. We will consider each of these outcomes
separately, outlining potential pathways and underlying mech-
anisms linking maternal pregnancy diabetes with offspring
outcomes, including potential mediation by epigenetic pro-
cesses, namely DNA methylation. These will anchor our re-
view of the literature as we critically assess whether it supports
a direct causal relationship between maternal pregnancy dia-
betes and these long-term offspring health outcomes, or not.
Potential pathways linking maternal pregnancy diabetes
and offspring long-term adiposity, cardiometabolic health,
and cognitive ability are illustrated in Fig. 1. As can be seen,
pathways depicting a direct effect of exposure to maternal
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diabetes in utero (as opposed to common genetic or environ-
mental causes pathways), suggest that all diabetes types affect
offspring outcomes via the same biological mechanisms, ie,
the delivery of excess and/or fluctuating levels of nutrients to
the fetus, which in turn influences fetal development and long-
term outcomes. Associations between maternal glucose levels
in pregnancy and neonatal outcomes including birth weight
and adiposity have been shown to be graded across the entire
distribution of glucose even in normoglycemic women, with
no threshold effect [12••, 13]. It is likely that this is the case for
long-term outcomes as well. However, women who have
entered pregnancy with pre-existing diagnosed diabetes (type
1 or type 2) are more likely to have received counselling and
monitoring and hence, have better controlled glucose levels
than women diagnosed with gestational diabetes, ie, in the
second or third trimester of pregnancy. Thus, offspring ex-
posed to gestational diabetes as opposed to pre-existing type 1
or type 2 diabetes, may have been exposed to higher circulat-
ing levels of glucose at the earlier stages of pregnancy [14•].
Offspring Adiposity and Cardiometabolic Health
Infants of diabetic mothers are often macrosomic or large for
gestational age (LGA) [15–17]. This is due to increased
delivery of glucose to the developing fetus. Glucose crosses
the placenta while maternal insulin does not. As a result, fetal
insulin production is increased, which in turn increases insulin
mediated fetal fat deposition and skeletal growth [18•]. The
observation that diabetic mothers have larger babies gave rise
to the developmental overnutrition hypothesis, which extends
this relationship both to maternal adiposity and to lasting
effects on adiposity and related cardiometabolic measures that
go beyond birth into childhood, adolescence, and even adult-
hood [14•]. Here we focus on the long-term consequences of
maternal pregnancy diabetes, and readers are referred to 2
previous publications for further discussion of the evidence
regarding long-term consequences of maternal adiposity, and
gestational weight gain [14•, 18•], and for a summary of the
evolution of the developmental overnutrition hypothesis [14•].
It is important to understand whether maternal diabetes
(and indeed greater adiposity, which is not addressed here) is
associated with lasting greater offspring adiposity and more
adverse cardiometabolic health via intrauterine mechanisms
given that developmental overnutrition could perpetuate the
obesity epidemic across future generations. For this reason it
is also important to identifying the exact nature of these
mechanisms. According to the developmental overnutrition
hypothesis female offspring of mothers with diabetes enter
their own pregnancies more adipose, at greater risk of having
Fig. 1 Schematic representation of potential pathways linking maternal
diabetes in pregnancy with long- term offspring greater adiposity, adverse
cardiometabolic health and lower cognitive ability. The figure is illustra-
tive of the focus of this article and does not aim to show all possible
relationships between the characteristics that are depicted. Pathways
specific to offspring adiposity and cardiometabolic health are given in
italics and pathways specific to cognitive ability in bold with common
pathways in standard font. Adapted from Lawlor DA. The Society for
Social Medicine John Pemberton lecture 2011. Developmental overnu-
trition—an old hypothesis with new importance? Int J Epidemiol.
2013;42:7–29 [14•]; and Fraser A, Almqvist C, Larsson H, Långström
N, Lawlor D. Maternal diabetes in pregnancy and offspring cognitive
ability: sibling study with 723,775 men from 579,857 families.
Diabetologia. 2013;1–8 [47], which is published under the CC-BY
license.)
489, Page 2 of 8 Curr Diab Rep (2014) 14:489
diabetes in pregnancy, with consequences for their own
offspring.
A growing number of reports based on data from prospec-
tive pregnancy cohorts support the developmental overnutri-
tion hypothesis, for example [19, 20]. Interestingly, 2 recent
systematic reviews [21, 22] suggested that the evidence
supporting association between gestational diabetes [21],
pregnancy diabetes [22], and greater offspring adiposity is
still inconclusive. This conclusion was based on the reported
attenuation of associations between pregnancy diabetes and
offspring adiposity upon adjustment for maternal
prepregnancy body mass index (BMI) in some studies. How-
ever, many of the studies included in these reviews were
conducted in European and North American countries, in
which screening for gestational diabetes is not universal and
is only offered to women considered to be at high risk. This is
likely to result in bias by indication [14•]. In other words, there
will be more normal weight women with diabetes who are
misclassified as nondiabetic because they will have been
unlikely to have been offered a diagnostic oral glucose toler-
ance test than overweight or obese women. This means that
adjustment for pre- or early pregnancy BMI results in over-
attenuation of the association between pregnancy diabetes and
offspring outcomes [14•].
Although observational studies do not in themselves pro-
vide proof for a role of direct intra-uterine mechanisms, a
consistent body of evidence suggests that inheritance of genes
predisposing to diabetes and/or shared behavior and other
environmental exposures only partly explain associations of
maternal pregnancy diabetes and offspring greater adiposity
and associated adverse cardiometabolic health. Family based
studies of the Pima Indians of Arizona, a population with a
very high prevalence of obesity and type 2 diabetes, have
yielded convincing evidence that exposure to diabetes in
pregnancy per se results in greater mean body mass index
(BMI), fasting glucose and insulin, and risk of type 2 diabetes
in offspring (during childhood, adolescence, and early adult-
hood). This body of work has been reviewed in detail else-
where [14•, 23•, 24]. Briefly, it has shown that offspring born
to mothers who had diabetes during their pregnancy had
greater mean body mass index (BMI), fasting glucose and
insulin and risk of type 2 diabetes compared with either the
offspring of mothers who developed diabetes later in their
lives or those who never developed diabetes [24, 25]. Sibling
studies are a powerful approach for determining causality as
they inherently control for maternal genetic variation and any
environmental exposures that have remained constant or very
similar across pregnancies. Hence, in this context, a difference
in the risk of obesity and type 2 diabetes between siblings is
likely due, at least in part, to discordant exposure to maternal
diabetes in-utero. The same study also found that within
siblings there was no association of paternal diabetes around
the time of pregnancy with these offspring outcomes [25].
Comparing the association of paternal and maternal diabetes
with offspring outcomes is another way of exploring whether
exposure to diabetes in utero is causally associated with off-
spring outcomes. If exposure to diabetes in utero directly
affects the offspring the maternal-offspring association will
be much stronger than the paternal-offspring association.
However, associations driven by shared familial, social, ge-
netic, and environmental factors are likely to produce similar
maternal-paternal associations. Therefore, findings from the
Pima sibling study suggest that, at least in a population at high
risk for obesity and diabetes, intra-uterine mechanisms make
an important contribution to the link between gestational
diabetes and offspring greater adiposity, insulin resistance,
and type 2 diabetes.
More recently, a large study of Swedish men included a
within sibling analysis (280,866 men from 248,293 families)
and found that the BMI of men whose mothers had diabetes
during their pregnancy was on average 0.94 kg/m2 greater
(95 % CI: 0.35, 1.52) than in their brothers born before their
mother was diagnosed with diabetes [26]. There was no
within-sibling association of maternal early pregnancy BMI
in that study, and adjustment for it did not alter the diabetes-
offspring BMI association. These findings suggest that in a
European population with a much lower rate of pregnancy
diabetes than the Pima Indians of Arizona, intra-uterine mech-
anisms contribute importantly to the link between maternal
diabetes in pregnancy and later offspring adiposity and that
this association is not strongly confounded by early pregnancy
BMI.
Offspring Cognitive Abilities
As already noted, maternal diabetes in pregnancy is associated
with a number of neonatal complications and it has been
postulated that these may, in turn, adversely affect offspring
cognitive development [27, 28]. It is also possible that mater-
nal diabetes in pregnancy affects fetal neurocognitive devel-
opment and long-term cognitive ability through altered brain
structure caused by in-utero exposure to a metabolic milieu,
which incorporates high or fluctuating concentrations of glu-
cose, and potentially ketonemia [29]. This hypothesized path-
way is similar to the developmental overnutrition hypothesis
but is concerned with cognitive development. Alternatively,
pleiotropic effects of genes shared by mother and offspring
that are related to both risk of diabetes and IQ could result in
an association between pregnancy diabetes and offspring cog-
nition. Finally, shared familial environmental exposures such
as socioeconomic position, educational attainment, levels of
physical activity and nutrition may result in associations be-
tween pregnancy diabetes and impaired offspring cognitive
ability. These potential pathways are summarized in Fig. 1.
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A number of studies have compared the cognitive abilities
of offspring of mothers with pregnancy diabetes to offspring
of mothers without pregnancy diabetes at different ages and
using different measures of cognitive ability [28, 30–36].
Even though studies have reported lower scores in offspring
of women with pregnancy diabetes on some indices, differ-
ences in overall IQ have been observed only for women with
gestational diabetes and in younger ages [30, 34, 37]. Recent
studies have examined associations between pregnancy dia-
betes and measures of educational attainment. Arguably, these
are more significant outcomes as they have a direct impact on
future educational and occupational outcomes. In a large
Swedish record linkage study of 6397 offspring of mothers
with pregnancy diabetes and ~1.3 children to mothers without
pregnancy diabetes, maternal diabetes in pregnancy was as-
sociated with a greater risk of not completing compulsory
schooling at the age of 16 (OR=1.25; 95%CI: .10–1.43),
and with a lower mean school mark [38]. Similarly, in the
UK Avon Longitudinal Study of Parents and Children
(ALSPAC), pre-existing diabetes (likely to diabetes type;
N=20 to 26 varying by outcome), gestational diabetes (N=
23 to 31), and, to a lesser extent, glycosuria (N=160 to 240)
were associated with lower offspring School Entry Assess-
ment scores (at age 4), IQ (at age 8), and school results (GCSE
results, at age 16) even when adjusting for potential con-
founders such as prepregnancy BMI, maternal smoking in
pregnancy, parity, mode of delivery, maternal education, and
social class [39]. In contrast to those 2 studies in populations
with relatively low rates of pregnancy diabetes (0.5 %), in an
Indian population characterized by higher rates of pregnancy
diabetes (7 %), offspring of women with gestational diabetes
(N=32) scored higher on a variety of cognitive tests compared
with offspring of women without gestational diabetes (N=
483) at a mean age of 9.7 years, though after adjusting for a
range of potential confounders, differences were somewhat
attenuated toward the null [40].
Smaller studies have reported correlations between indices
of maternal metabolic control in women with and without
pregnancy diabetes (eg, glucose, beta-hydroxybutyrate, free
fatty acids, acetonuria), and offspring cognitive abilities in
childhood. Here too, results have been mixed, with positive
or null associations between different measures of metabolic
control and different measures of cognitive ability found in the
same study populations [27, 28, 41]. More recently, Nielsen
et al reported negative associations between maternal preg-
nancy glycated hemoglobin (A1c) levels and offspring cogni-
tive ability assessed at 18-20 years of age (N=39) [42], as well
as between pregnancy fasting blood glucose levels of insulin
treated diabetic mothers and offspring cognitive ability
assessed in early adulthood (N=60) [43].
If associations between better maternal metabolic control in
pregnancy and lower offspring cognitive ability are causal,
this would be additional evidence supporting the need to
identify and control glucose intolerance in pregnancy. How-
ever, observational epidemiologic studies may be affected by
confounding, reverse causation and bias, and therefore, it is
problematic to infer causality from their results. Two recent
studies have employed different strategies to tackle these
shortcomings with regard to associations between pregnancy
diabetes and offspring cognitive abilities.
AMendelian randomization approach uses genetic variants
that are reliably associated with a modifiable exposure to
make inferences about the causal effect of this exposure on
an outcome of interest [44, 45]. This instrumental variable
approach assumes that a genetic variant is associated with a
trait of interest, here pregnancy diabetes; that the association
between the variant and the trait is independent of unmeasured
confounders and that the variant is associated with the out-
come only through its association with the specific trait [45].
Thus, such an approach yields an unconfounded causal esti-
mate of the association between exposure and outcome.
Bonilla et al studied associations of maternal fasting glucose
genetic risk scores and maternal type 2 diabetes genetic risk
score with offspring IQ assessed at 8 years of age in the
ALSPAC cohort [46]. Genetic risk scores combine data on
multiple genetic variants that are known to be associated with
a given trait and are used as they explain more of the variation
in the trait than a single variant on its own. When these scores
are then related to an outcome this provides a statistical test for
whether that trait (with it, rather than the genes, being the risk
factor of interest), is causally related to the outcome [44, 45].
In this study, authors found a positive association between
maternal fasting glucose risk scores and offspring IQ, ie, a
higher maternal risk score (indicative of higher fasting glu-
cose) was associated with higher offspring IQ, but the confi-
dence interval was wide and included the null value. A
positive association was also found between maternal type 2
diabetes risk scores and offspring IQ even when adjusting for
offspring’s own type 2 diabetes risk score; altough the confi-
dence interval for this association was also wide, it did not
include the null value. These findings suggest that maternal
pregnancy diabetes and perhaps higher fasting glucose levels
may result in greater offspring IQ in childhood.
In a sibling study using data from the Swedish population
registers, we examined associations of maternal pregnancy
diabeteswithmale offspring educational attainment at 16 years
of age and IQ assessed at 18 years of age at the national
conscription assessment. In nonsiblings, men whose mother
had pregnancy diabetes had an IQ that was on average –1.36
points (95 % CI: –2.12, –0.60) lower than men whose mothers
did not have diabetes in pregnancy even when adjusting for
birth year, maternal age, education, and BMI in early preg-
nancy, parity as well as gestational age and birth weight. In
comparison, there was no such association within sibships. In
fact, siblings exposed to maternal diabetes in pregnancy had,
on average, a higher IQ compared with their unexposed
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siblings: mean difference = 1.70; 95 % CI: –1.80, 5.21 (p
value for difference between the 2 estimates 0.08). A similar
pattern was found for school grades: in the whole population
school grades of offspring of women with pregnancy diabetes
were lower compared with offspring of women without dia-
betes in nonsiblings, even when adjusting for potential con-
founders, whilst associations were in the opposite direction
with confidence intervals spanning the null value within
sibships [47]. These results suggest that similarities shared
by siblings and inherently controlled for when comparing
siblings account for the associations between maternal preg-
nancy diabetes and lower cognitive ability observed in the
cohort as a whole and between nonsiblings. In other words,
findings suggest that a direct effect of exposure to a diabetic
milieu and/or perinatal complications resulting from maternal
diabetes (Fig. 1) are unlikely explanations for the associations
between maternal diabetes in pregnancy and lower offspring
cognitive abilities in the overall population.
Even as most observational studies report associations
between exposure to maternal pregnancy diabetes, worse met-
abolic control, and lower offspring cognitive ability, there are
now 3 different studies [40, 46, 47] with findings that support
an opposite, positive effect of exposure to maternal pregnancy
diabetes on long-term cognitive ability. The Swedish sibling
study [47] found the expected association of maternal preg-
nancy diabetes with lower cognitive ability in the population
as a whole but an analysis restricted to siblings discordant in
their exposure to maternal pregnancy diabetes in utero sug-
gested that exposure to maternal pregnancy diabetes was
associated with higher cognitive ability, though statistical
power was limited. These results point to shared environmen-
tal or genetics as drivers of the observed association between
maternal pregnancy diabetes and lower cognitive ability in
adolescence and early adulthood. At this time we are unaware
of any existing evidence of genetic variants that are associated
with both diabetes and cognitive ability (genetic pleiotropy)
and hence, could explain the observed association of pregnan-
cy diabetes with lower cognitive ability. Similarly, a Mende-
lian randomization study results are consistent with a protec-
tive effect of maternal pregnancy diabetes on fetal brain de-
velopment [46], though, like the sibling comparison it too was
hampered by limited statistical power.
Mediation by Epigenetic Processes
Epigenetic modifications, such as DNA methylation, regulate
gene expression without altering the underlying DNA se-
quence. They have been shown to occur in response to envi-
ronmental stimuli [48], are common duringmitosis and hence,
during fetal development, and to be stable over time [49].
Hence, they are a plausible mediator of the effect of intrauter-
ine exposures, such as exposure to maternal pregnancy diabe-
tes, on offspring outcomes and are increasingly studied in this
regard. In relation to the topic of this reviewmost studies have
examined the potential of epigenetic modification to influence
future offspring greater adiposity and adverse cardiometabolic
health than their cognitive function.
For epigenetic mechanisms to play an important part on the
causal pathway between maternal pregnancy diabetes and
offspring later adiposity, cardiometabolic and cognitive out-
comes, there would need to be: (I) a causal effect of maternal
diabetes on the fetal epigenome and (II) a causal effect of the
specific fetal epigenome modifications resulting from preg-
nancy diabetes, on later offspring outcomes. To our knowl-
edge to date no study has examined associations of this full
chain (ie, the association of pregnancy diabetes with offspring
epigenome and of it with later offspring outcomes). Therefore,
here we first describe studies of: (I) maternal diabetes with
fetal epigenome as the outcome and then of (II) associations of
fetal epigenome as the exposure with later adiposity and
cardiometabolic health. We then briefly discuss how causal
epigenomic mediation might be tested. Whilst epigenetic
mechanisms have been implicated in the etiology of cognitive
function and disorders [50], we are unaware of any studies
examining associations of fetal epigenome with cognitive
outcomes later in life.
Maternal Pregnancy Diabetes and Fetal Epigenome
Bouchard et al reported finding no difference in mean DNA
methylation levels of the leptin gene in placental tissue be-
tween 23 women who had experienced gestational diabetes
and 25 age- and BMI-matched controls. However, in those
with gestational diabetes, 2-hour postload glucose was in-
versely correlated with fetal-side placental tissue DNA meth-
ylation of the leptin gene, but positively correlated with this in
maternal-side tissue [51]. In a second study from the same
group, maternal 2-hour postload glucose was inversely asso-
ciated with DNA methylation levels of the adiponectin gene
on the fetal side of the placenta in 98 women [52]. In a third
study, genome wide methylation profiles of placenta and cord
blood samples of 30 women with gestational diabetes and 14
women without gestational diabetes assessed using the
Infinium HumanMethylation450 BeadChips [53]. Authors
found numerous differentially methylated genes (3271 and
3758 genes in placenta and cord blood, respectively, with
25 % overlap), though none reached the epigenome-wide
significance level. Ingenuity pathway analysis suggested that
genes predominantly involved in metabolic disease pathways
were differentially methylated in women with gestational
diabetes compared with those without [53]. In another study
[54], DNA methylation levels at the maternally imprinted
MEST gene were significantly lower in placenta and cord
blood of women with gestational diabetes (88 treated dieteti-
cally and 98 with insulin) than in those without gestational
diabetes. This study also found that morbidly obese adults had
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a decreased bloodMESTmethylation compared with normal-
weight adults (N=37 in each group). Animal models suggest
that MEST plays a role in the development of obesity.
Fetal Epigenome and Long-Term Health
Several studies have examined associations of DNA methyl-
ation with later adiposity and cardiometabolic outcomes. In 1
study DNA methylation of the promoter regions of 5 candi-
date genes (RXRA, eNOS, SOD1, IL8, and PI3KCD) in um-
bilical cord tissue was related to dual X-ray absorptiometry
(DXA)-determined fat mass in childhood, but only DNA
methylation in RXRAwas found to relate to later fat mass in
the discovery (N=78) and replication (N=239) cohorts [55].
In another study, DNA methylation at 24 candidate gene sites
in cord blood white cells were related to a range of anthropo-
metric outcomes and differential methylation at 5 sites was
associated with offspring BMI and/or fat mass at age 9 (N=
178), but none of these associations withstood adjustment for
multiple statistical tests [56]. Lastly, in a study using 3 inde-
pendent samples (N=21, 107, and 154) of white blood cell
collected in childhood or adolescence, DNA hypermethyla-
tion in intron 2 and 3 of POMC, a gene known to be related to
greater BMI and obesity risk, was found to be associated with
obesity [57]. In a separate sample, the pattern of DNA meth-
ylation in POMC in normal weight individuals was found to
be stable between birth and 18 years, and was also the same as
that found in the same sites in neurons of the hypothalamic
arcuate nucleus obtained at postmortem from normal weight
adults (N=5). It was also found that the obesity related pattern
of DNA hypermethylation was present prior to the develop-
ment of obesity, leading the authors to conclude that the
methylation patterns in POMC appears to occur early in
embryogenesis, persist across life and is related to obesity.
Associations of variation in DNA methylation levels and
exposures or outcomes of interest are susceptible to ‘classic’
confounding [58, 59]. Hence, associations of maternal gesta-
tional diabetes with DNA methylation and of the latter with
adiposity and cardiometabolic health do not prove causality.
Larger studies, further replication and the use of analytical
approaches for determining causality and whether differential
DNA methylation in offspring is indeed a mediator or not are
important next steps in following up these highly interesting
but tentative observations. Two-step epigenetic Mendelian
randomization is one such analytical approach. As in a Men-
delian randomization approach (described above), genetic
variants are used as a proxy for an exposure of interest (here
pregnancy diabetes) in step 1. In step 2, a genetic variant is
used as a proxy for methylation and related to an outcome of
interest (here long- term offspring adiposity, cardiometabolic
outcomes or cognitive ability). Each step can be examined
separately or both can be jointly interrogating thus, testing the
entire pathway. This approach is not without its limitations
(see [58, 59] for detailed discussions) but it also has the
potential to significantly further our understanding of the
putative role of DNA methylation as a mediator in associa-
tions of pregnancy diabetes and offspring long- term health.
Conclusions
Current evidence supports a direct causal role for exposure to
maternal diabetes in utero in determining offspring long- term
greater adiposity and adverse cardiometabolic health. Whilst a
majority of observational studies report associations of expo-
sure to maternal pregnancy diabetes with lower cognitive
ability, there is also evidence supporting an opposite ‘protec-
tive’ intrauterine effect of exposure to maternal pregnancy
diabetes on offspring cognitive ability. Differential DNA
methylation may play a role in mediating these effects but
research in this area is still novel.
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